Literature DB >> 11326662

Tu-M2-PK in the blood of testicular and cubital veins in men with testicular cancer.

T Pottek1, M Müller, T Blum, M Hartmann.   

Abstract

We wanted to verity whether M2-PK is a useful marker in testicular cancer. In a prospective study of 20 consecutive patients, blood was drawn from the testicular and the cubital vein before semicastration and later. For the detection of M2-PK we used the Assay of ScheboTech. In the testicular vein M2-PK was 11.2 U/ml. In the cubital vein it was 6.2 U/ml before semicastration, increasing in the following days. There were no significant differences between testicular and cubital vein blood, between the non-metastasized patients and the metastasized stages and between the patients with seminoma and non-seminomatous tumors. There is no profit in the diagnosis of testicular cancer using Tu-M2-PK.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11326662

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

1.  Tumor type M2 pyruvate kinase expression in gastric cancer, colorectal cancer and controls.

Authors:  Bo Zhang; Jian-Ying Chen; Dao-Da Chen; Guo-Bin Wang; Ping Shen
Journal:  World J Gastroenterol       Date:  2004-06-01       Impact factor: 5.742

2.  PKM2 in Canine Mammary Tumors: Parallels to Human Breast Cancer.

Authors:  Hyo-Ju Lee; Hyo-Jeong Han; Ji-Young Lee; Woo-Chan Son
Journal:  Comp Med       Date:  2020-07-27       Impact factor: 0.982

3.  PKM2, a Central Point of Regulation in Cancer Metabolism.

Authors:  Nicholas Wong; Jason De Melo; Damu Tang
Journal:  Int J Cell Biol       Date:  2013-02-14

4.  Synergistic combination of gemcitabine and dietary molecule induces apoptosis in pancreatic cancer cells and down regulates PKM2 expression.

Authors:  Archana Pandita; Bhupender Kumar; Siddharth Manvati; Samantha Vaishnavi; Shashank K Singh; Rameshwar N K Bamezai
Journal:  PLoS One       Date:  2014-09-08       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.